These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 32265358

  • 1. Equivalent Survival of p53 Mutated Endometrial Endometrioid Carcinoma Grade 3 and Endometrial Serous Carcinoma.
    Brett MA, Atenafu EG, Singh N, Ghatage P, Clarke BA, Nelson GS, Bernardini MQ, Köbel M.
    Int J Gynecol Pathol; 2021 Mar 01; 40(2):116-123. PubMed ID: 32265358
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry.
    Fadare O, Parkash V.
    Diagn Pathol; 2017 Nov 14; 12(1):81. PubMed ID: 29137657
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TP53 Mutational Spectrum in Endometrioid and Serous Endometrial Cancers.
    Schultheis AM, Martelotto LG, De Filippo MR, Piscuglio S, Ng CK, Hussein YR, Reis-Filho JS, Soslow RA, Weigelt B.
    Int J Gynecol Pathol; 2016 Jul 14; 35(4):289-300. PubMed ID: 26556035
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinicopathologic characteristics and outcomes of endometrial Cancer patients with mismatch repair deficiency in the era of universal Lynch syndrome screening.
    Carr C, Son J, Yao M, Priyadarshini A, Marquard J, Vargas R, Michener C, AlHilli MM.
    Gynecol Oncol; 2020 Dec 14; 159(3):712-720. PubMed ID: 33046272
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas.
    Allo G, Bernardini MQ, Wu RC, Shih IeM, Kalloger S, Pollett A, Gilks CB, Clarke BA.
    Mod Pathol; 2014 Feb 14; 27(2):255-61. PubMed ID: 23887303
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Expression of p53 in imprint smears of endometrial carcinoma.
    Kosmas K, Stamoulas M, Marouga A, Kavantzas N, Patsouris E, Athanassiadou P.
    Diagn Cytopathol; 2014 May 14; 42(5):416-22. PubMed ID: 24167025
    [Abstract] [Full Text] [Related]

  • 16. Concomitant PI3K-AKT and p53 alterations in endometrial carcinomas are associated with poor prognosis.
    Catasus L, Gallardo A, Cuatrecasas M, Prat J.
    Mod Pathol; 2009 Apr 14; 22(4):522-9. PubMed ID: 19234438
    [Abstract] [Full Text] [Related]

  • 17. POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.
    Meng B, Hoang LN, McIntyre JB, Duggan MA, Nelson GS, Lee CH, Köbel M.
    Gynecol Oncol; 2014 Jul 14; 134(1):15-9. PubMed ID: 24844595
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.
    Van Gool IC, Stelloo E, Nout RA, Nijman HW, Edmondson RJ, Church DN, MacKay HJ, Leary A, Powell ME, Mileshkin L, Creutzberg CL, Smit VT, Bosse T.
    Mod Pathol; 2016 Feb 14; 29(2):174-81. PubMed ID: 26743472
    [Abstract] [Full Text] [Related]

  • 19. Correlative Assessment of p53 Immunostaining Patterns and TP53 Mutation Status by Next-Generation Sequencing in High-Grade Endometrial Carcinomas.
    Matsumoto N, Manrai P, Rottmann D, Wu X, Assem H, Hui P, Buza N.
    Int J Gynecol Pathol; 2023 Nov 01; 42(6):567-575. PubMed ID: 36730675
    [Abstract] [Full Text] [Related]

  • 20. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I, D'Angelo E, Corominas M, Gonzalez A, Prat J.
    Hum Pathol; 2018 Jan 01; 71():65-73. PubMed ID: 29079180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.